Alltrna
Signal active
Organization
Contact Information
Overview
Alltrna is the tRNA platform company to decipher tRNA biology and pioneer tRNA therapeutics to treat thousands of diseases. tRNAs play a central role in the translation of mRNA into proteins. tRNA biology modulates the complex code of DNA and RNA across translation and transcription. Altrna platform incorporates AI/ML tools to learn the tRNA language and deliver diverse programmable molecules with broad therapeutic potential.
About
Industries
Biotechnology, Health Care, Therapeutics
Founded
2018
Employees
51-100
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Alltrna headquartered in United States, North America, operates in the Biotechnology, Health Care, Therapeutics sector. The company focuses on Biotechnology and has secured $3.8B in funding across 24 round(s). With a team of 51-100 employees, Alltrna is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Alltrna, raised $109.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
1
Lead Investors
0
Total Funding Amount
$159.0M
Details
1
Alltrna has raised a total of $159.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Early Stage Venture | 109.0M |
Investors
Alltrna is funded by 9 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Lovisa Afzelius | - | FUNDING ROUND - Lovisa Afzelius | 109.0M |
| Noubar Afeyan | - | FUNDING ROUND - Noubar Afeyan | 109.0M |
| Alltrna | - | FUNDING ROUND - Alltrna | 109.0M |
| Flagship Pioneering | - | FUNDING ROUND - Flagship Pioneering | 109.0M |
Recent Activity
There is no recent news or activity for this profile.